FY2024 Earnings Estimate for BioSyent Issued By Bloom Burton

BioSyent Inc. (CVE:RX) – Bloom Burton raised their FY2024 earnings estimates for shares of BioSyent in a report issued on Thursday, November 21st. Bloom Burton analyst D. Martin now anticipates that the company will earn $0.63 per share for the year, up from their prior forecast of $0.59. The consensus estimate for BioSyent’s current full-year earnings is $0.69 per share. Bloom Burton also issued estimates for BioSyent’s FY2025 earnings at $0.80 EPS and FY2026 earnings at $0.91 EPS.

BioSyent (CVE:RX) last announced its quarterly earnings data on Monday, August 26th. The company reported C$0.13 earnings per share for the quarter, hitting the consensus estimate of C$0.13. The firm had revenue of C$8.95 million during the quarter, compared to analysts’ expectations of C$8.80 million. BioSyent had a return on equity of 20.88% and a net margin of 21.14%.

BioSyent Trading Up 0.4 %

Shares of CVE RX opened at C$11.25 on Monday. BioSyent has a fifty-two week low of C$8.20 and a fifty-two week high of C$11.49. The firm has a market capitalization of C$130.39 million, a P/E ratio of 18.75 and a beta of 0.93. The company has a debt-to-equity ratio of 3.19, a current ratio of 6.13 and a quick ratio of 6.91. The company’s 50 day simple moving average is C$11.05 and its 200 day simple moving average is C$10.27.

Insider Buying and Selling

In other news, Director Seyed Ahmad Ashrafi sold 2,320 shares of the firm’s stock in a transaction dated Friday, September 20th. The stock was sold at an average price of C$10.95, for a total transaction of C$25,404.00. 33.65% of the stock is owned by insiders.

About BioSyent

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.